Completed PHASE4 INTERVENTIONAL NCT00161083

UDCA for Symptomatic Gallstone Disease

Studie Naar De Effectiviteit Van Ursodeoxycholzuur Ter Preventie Van Galsteen-Gerelateerde Klachten Bij patiënten in Afwachting Van Een Cholecystectomie

Sponsor: Agis Zorgverzekeringen

Conditions Cholecystolithiasis

Interventions ursodeoxycholic acid

Updated 5 times since 2017 Last updated: Jul 26, 2006 Started: Nov 30, 2001 Completion: Nov 30, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cholecystolithiasis, this trial is completed. The trial is conducted by Agis Zorgverzekeringen and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Agis Zorgverzekeringen
Dr. Falk Pharma GmbH
Dutch Digestive Diseases Foundation
UMC Utrecht
ZonMw: The Netherlands Organisation for Health Research and Development

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands